Epstein-Barr virus latency: Current and future perspectives

Current Opinion in Virology

Volumn 14, Issue , 2015, Pages 138-144

  Kempkes, Bettina ^a   Robertson, Erle S ^b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; EBNA3A PROTEIN; EBNA3C PROTEIN; EPSTEIN BARR VIRUS ANTIGEN 2; LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; UBIQUITIN; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

AUTOPHAGOSOME; B LYMPHOCYTE; CELL DEATH; CELL PROLIFERATION; CHROMATIN; ENHANCER REGION; EPIGENETICS; EPSTEIN BARR VIRUS; HUMAN; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS LATENCY; VIRUS TRANSCRIPTION; CARCINOGENESIS; GENE EXPRESSION REGULATION; HOST PATHOGEN INTERACTION; PHYSIOLOGY;

CARCINOGENESIS; GENE EXPRESSION REGULATION; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; VIRUS LATENCY;

EID: 84943379942     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2015.09.007     Document Type: Review

References (50)

1. A.B. Rickinson Co-infections, inflammation and oncogenesis: future directions for EBV research Semin Cancer Biol 26 2014 99 115
2. M.S. Kang, and E. Kieff Epstein-Barr virus latent genes Exp Mol Med 47 2015 e131
3. J.I. Cohen Epstein-barr virus vaccines Clin Transl Immunol 4 2015 e32
4. C.J. Houldcroft, and P. Kellam Host genetics of Epstein-Barr virus infection, latency and disease Rev Med Virol 25 2015 71 84
5. D.A. Thorley-Lawson, J.B. Hawkins, S.I. Tracy, and M. Shapiro The pathogenesis of Epstein-Barr virus persistent infection Curr Opin Virol 3 2013 227 232
6. S. Halder, M. Murakami, S.C. Verma, P. Kumar, F. Yi, and E.S. Robertson Early events associated with infection of Epstein-Barr virus infection of primary B-cells PLoS One 4 2009 e7214
7. A. Saha, and E.S. Robertson Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes Clin Cancer Res: Off J Am Assoc Cancer Res 17 2011 3056 3063
8. A.M. Price, and M.A. Luftig To be or not IIb: a multi-step process for Epstein-Barr virus latency establishment and consequences for B cell tumorigenesis PLoS Pathog 11 2015 e1004656
9. A. Aiyar, S. Aras, A. Washington, G. Singh, and R.B. Luftig Epstein-Barr Nuclear Antigen 1 modulates replication of oriP-plasmids by impeding replication and transcription fork migration through the family of repeats Virol J 6 2009 29
10. L. Frappier EBNA1 and host factors in Epstein-Barr virus latent DNA replication Curr Opin Virol 2 2012 733 739
11. A. Arvey, I. Tempera, K. Tsai, H.S. Chen, N. Tikhmyanova, M. Klichinsky, C. Leslie, and P.M. Lieberman An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions Cell Host Microbe 12 2012 233 245
12. E.P. Consortium, I. Dunham, A. Kundaje, S.F. Aldred, P.J. Collins, C.A. Davis, F. Doyle, C.B. Epstein, S. Frietze, J. Harrow, and et al. An integrated encyclopedia of DNA elements in the human genome Nature 489 2012 57 74
13. R. Baer, A.T. Bankier, M.D. Biggin, P.L. Deininger, P.J. Farrell, T.J. Gibson, G. Hatfull, G.S. Hudson, S.C. Satchwell, C. Seguin, and et al. DNA sequence and expression of the B95-8 Epstein-Barr virus genome Nature 310 1984 207 211
14. H. Kwok, C.W. Wu, A.L. Palser, P. Kellam, P.C. Sham, D.L. Kwong, and A.K. Chiang Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples J Virol 88 2014 10662 10672
15. A.L. Palser, N.E. Grayson, R.E. White, C. Corton, S. Correia, M.M. Ba Abdullah, S.J. Watson, M. Cotten, J.R. Arrand, P.G. Murray, and et al. Genome diversity of Epstein-barr virus from multiple tumor types and normal infection J Virol 89 2015 5222 5237
16. M.L. Harth-Hertle, B.A. Scholz, F. Erhard, L.V. Glaser, L. Dolken, R. Zimmer, and B. Kempkes Inactivation of Intergenic Enhancers by EBNA3A Initiates and Maintains Polycomb Signatures across a Chromatin Domain Encoding CXCL10 and CXCL9 PLoS Pathog 9 2013 e1003638
17. M.J. McClellan, C.D. Wood, O. Ojeniyi, T.J. Cooper, A. Kanhere, A. Arvey, H.M. Webb, R.D. Palermo, M.L. Harth-Hertle, B. Kempkes, R.G. Jenner, and M.J. West Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming PLoS Pathog 9 2013 e1003636
18. D. Portal, H. Zhou, B. Zhao, P.V. Kharchenko, E. Lowry, L. Wong, J. Quackenbush, D. Holloway, S. Jiang, Y. Lu, and E. Kieff Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2 Proc Natl Acad Sci USA 110 2013 18537 18542
19. B. Zhao, J. Zou, H. Wang, E. Johannsen, C.W. Peng, J. Quackenbush, J.C. Mar, C.C. Morton, M.L. Freedman, S.C. Blacklow, and et al. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth Proc Natl Acad Sci USA 108 2011 14902 14907
20. H. Zhou, S.C. Schmidt, S. Jiang, B. Willox, K. Bernhardt, J. Liang, E.C. Johannsen, P. Kharchenko, B.E. Gewurz, E. Kieff, and B. Zhao Epstein-Barr virus oncoprotein super-enhancers control B cell growth Cell Host Microbe 17 2015 205 216
21. M.J. Allday EBV finds a polycomb-mediated, epigenetic solution to the problem of oncogenic stress responses triggered by infection Front Genet 4 2013 212
22. M.J. McClellan, S. Khasnis, C.D. Wood, R.D. Palermo, S.N. Schlick, A.S. Kanhere, R.G. Jenner, and M.J. West Downregulation of integrin receptor-signaling genes by Epstein-Barr virus EBNA 3C via promoter-proximal and -distal binding elements J Virol 86 2012 5165 5178
23. K. Paschos, G.A. Parker, E. Watanatanasup, R.E. White, and M.J. Allday BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV Nucleic Acids Res 40 2012 7233 7246
24. L. Skalska, R.E. White, G.A. Parker, E. Turro, A.J. Sinclair, K. Paschos, and M.J. Allday Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines PLoS Pathog 9 2013 e1003187
25. M.L. Hertle, C. Popp, S. Petermann, S. Maier, E. Kremmer, R. Lang, J. Mages, and B. Kempkes Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes PLoS Pathog 5 2009 e1000506
26. S. Banerjee, J. Lu, Q. Cai, A. Saha, H.C. Jha, R.K. Dzeng, and E.S. Robertson The EBV latent antigen 3C inhibits apoptosis through targeted regulation of interferon regulatory factors 4 and 8 PLoS Pathog 9 2013 e1003314
27. J.S. Knight, N. Sharma, and E.S. Robertson SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen Mol Cell Biol 25 2005 1749 1763
28. A. Saha, and E.S. Robertson Impact of EBV essential nuclear protein EBNA-3C on B-cell proliferation and apoptosis Future Microbiol 8 2013 323 352
29. A. Saha, S. Halder, S.K. Upadhyay, J. Lu, P. Kumar, M. Murakami, Q. Cai, and E.S. Robertson Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1 PLoS Pathog 7 2011 e1001275
30. A. Saha, J. Lu, L. Morizur, S.K. Upadhyay, M.P. Aj, and E.S. Robertson E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells PLoS Pathog 8 2012 e1002573
31. J.R. Dixon, S. Selvaraj, F. Yue, A. Kim, Y. Li, Y. Shen, M. Hu, J.S. Liu, and B. Ren Topological domains in mammalian genomes identified by analysis of chromatin interactions Nature 485 2012 376 380
32. S. Selvaraj, R.D.J.V. Bansal, and B. Ren Whole-genome haplotype reconstruction using proximity-ligation and shotgun sequencing Nat Biotechnol 31 2013 1111 1118
33. R.M. Longenecker, E. Kieff, and J.I. Cohen Epstein-Barr virus 6 edn D.M. Knipe, P.M. Howley, J.I. Cohen, D.E. Griffin, R.A. Lamb, M.A. Martin, V.R. Racianello, B. Roizman, Fields Virology vol 2 2013 Lippincott Williams and Wilkins 1898 1959
34. S. Jiang, B. Willox, H. Zhou, A.M. Holthaus, A. Wang, T.T. Shi, S. Maruo, P.V. Kharchenko, E.C. Johannsen, E. Kieff, and B. Zhao Epstein-Barr Virus Nuclear Antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A Proc Natl Acad Sci USA 111 2014 421 426
35. S.C. Schmidt, S. Jiang, H. Zhou, B. Willox, A.M. Holthaus, P.V. Kharchenko, E.C. Johannsen, E. Kieff, and B. Zhao Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes Proc Natl Acad Sci USA 112 2015 554 559
36. S. Banerjee, J. Lu, Q. Cai, Z. Sun, H.C. Jha, and E.S. Robertson EBNA3C augments Pim-1 mediated phosphorylation and degradation of p21 to promote B-cell proliferation PLoS Pathog 10 2014 e1004304
37. C. Alfieri, M. Birkenbach, and E. Kieff Early events in Epstein-Barr virus infection of human B lymphocytes Virology 181 1991 595 608
38. A.M. Price, J.P. Tourigny, E. Forte, R.E. Salinas, S.S. Dave, and M.A. Luftig Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-kappaB activation J Virol 86 2012 11096 11106
39. B.E. Gewurz, J.C. Mar, M. Padi, B. Zhao, N.P. Shinners, K. Takasaki, E. Bedoya, J.Y. Zou, E. Cahir-McFarland, J. Quackenbush, and E. Kieff Canonical NF-kappaB activation is essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene regulation J Virol 85 2011 6764 6773
40. H. Greenfeld, K. Takasaki, M.J. Walsh, I. Ersing, K. Bernhardt, Y. Ma, B. Fu, C.W. Ashbaugh, J. Cabo, S.B. Mollo, and et al. TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation PLoS Pathog 11 2015 e1004890
41. L.S. Young, and A.B. Rickinson Epstein-Barr virus: 40 years on Nat Rev Cancer 4 2004 757 768
42. M.A. Calderwood, K. Venkatesan, L. Xing, M.R. Chase, A. Vazquez, A.M. Holthaus, A.E. Ewence, N. Li, T. Hirozane-Kishikawa, D.E. Hill, and et al. Epstein-Barr virus and virus human protein interaction maps Proc Natl Acad Sci USA 104 2007 7606 7611
43. K.M. Kaye, O. Devergne, J.N. Harada, K.M. Izumi, R. Yalamanchili, E. Kieff, and G. Mosialos Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein Proc Natl Acad Sci USA 93 1996 11085 11090
44. S.D. Ma, X. Xu, J. Plowshay, E.A. Ranheim, W.J. Burlingham, J.L. Jensen, F. Asimakopoulos, W. Tang, M.L. Gulley, E. Cesarman, J.E. Gumperz, and S.C. Kenney LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis J Clin Invest 125 2015 304 315
45. R. Longnecker Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence? Adv Cancer Res 79 2000 175 200
46. C.L. Miller, J.H. Lee, E. Kieff, and R. Longnecker An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking Proc Natl Acad Sci USA 91 1994 772 776
47. S. Swaminathan, B. Tomkinson, and E. Kieff Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro Proc Natl Acad Sci USA 88 1991 1546 1550
48. T.V. Sharp, D.A. Raine, D.R. Gewert, B. Joshi, R. Jagus, and M.J. Clemens Activation of the interferon-inducible (2′-5′) oligoadenylate synthetase by the Epstein-Barr virus RNA, EBER-1 Virology 257 1999 303 313
49. T.V. Sharp, M. Schwemmle, I. Jeffrey, K. Laing, H. Mellor, C.G. Proud, K. Hilse, and M.J. Clemens Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein-Barr virus RNAs EBER-1 and EBER-2 and adenovirus VAI RNA Nucleic Acids Res 21 1993 4483 4490
50. N. Lee, W.N. Moss, T.A. Yario, and J.A. Steitz EBV noncoding RNA binds nascent RNA to drive host PAX5 to viral DNA Cell 160 2015 607 618